AnaptysBio, Inc. ANAB Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $248.47M+4.3% | $238.2M+117% | $109.83M+148% | $44.3M-55.1% | $98.64M-19.9% | ||
| $37.99M-48.3% | $73.44M-47.2% | $139.12M-37.2% | $221.41M-8.2% | $241.3M-8.0% | ||
| $25.75M-23.9% | $33.85M-55.3% | $75.69M+253% | $21.42M+19.8% | $17.88M-56.1% | ||
| $3.91M-18.0% | $4.76M-20.8% | $6.01M+25.8% | $4.78M-9.7% | $5.29M-7.8% | ||
| $316.11M-9.7% | $350.25M+5.9% | $330.65M+13.3% | $291.91M-19.6% | $363.11M-15.9% | ||
| $1.28M-6.6% | $1.37M-8.7% | $1.5M-7.9% | $1.63M-6.5% | $1.74M-5.8% | ||
| $12.04M-3.8% | $12.52M-3.7% | $12.99M-3.5% | $13.46M-3.3% | $13.92M-3.2% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $329.68M-9.5% | $364.4M+3.2% | $353.1M+5.3% | $335.25M-20.6% | $422.05M-12.8% | ||
| $7.52M+94.2% | $3.87M+33.8% | $2.89M-13.1% | $3.33M-45.6% | $6.12M+53.0% | ||
| $32.07M-1.9% | $32.67M-1.5% | $33.17M+9.8% | $30.2M-16.0% | $35.95M-9.0% | ||
| $2.12M+1.9% | $2.08M+2.0% | $2.04M+1.9% | $2M+2.0% | $1.96M+1.9% | ||
| $41.7M+8.0% | $38.63M+1.4% | $38.1M+7.3% | $35.53M-19.3% | $44.04M-3.1% | ||
| $11.49M-4.5% | $12.03M-4.2% | $12.57M-4.0% | $13.1M-3.8% | $13.61M-3.5% | ||
| $13.61K-3.5% | $14.11K-99.9% | $14.61M-3.2% | $15.1M-3.1% | $15.58M-2.9% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $29K+3.6% | $28K0.0% | $28K0.0% | $28K-6.7% | $30K0.0% | ||
| $838.31M+3.5% | $809.77M+2.2% | $792.68M0.0% | $792.53M-4.8% | $832.49M+0.3% | ||
| -$825.44M-6.8% | -$772.56M+6.0% | -$822.17M+1.8% | -$837.29M-4.8% | -$798.66M-5.2% | ||
| -$146K-508% | -$24K-151% | $47K+883% | -$6K-104% | $161K-47.2% | ||
| $12.75M-65.7% | $37.21M+226% | -$29.42M+34.2% | -$44.73M-231% | $34.02M-52.0% | ||
| $329.68M-9.5% | $364.4M+3.2% | $353.1M+5.3% | $335.25M-20.6% | $422.05M-12.8% | ||
| $37.99M-48.3% | $73.44M-47.2% | $139.12M-37.2% | $221.41M-8.2% | $241.3M-8.0% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.04M-3.8% | $12.52M-3.7% | $12.99M-3.5% | $13.46M-3.3% | $13.92M-3.2% | ||
| $12.04M-3.8% | $12.52M-3.7% | $12.99M-3.5% | $13.46M-3.3% | $13.92M-3.2% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.04M-3.8% | $12.52M-3.7% | $12.99M-3.5% | $13.46M-3.3% | $13.92M-3.2% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $32.07M-1.9% | $32.67M-1.5% | $33.17M+9.8% | $30.2M-16.0% | $35.95M-9.0% | ||
| $32.07M-1.9% | $32.67M-1.5% | $33.17M+9.8% | $30.2M-16.0% | $35.95M-9.0% | ||
| $13.61K-3.5% | $14.11K-99.9% | $14.61M-3.2% | $15.1M-3.1% | $15.58M-2.9% | ||
| $29K+3.6% | $28K0.0% | $28K0.0% | $28K-6.7% | $30K0.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $263.74M-4.6% | $276.53M-16.7% | $331.84M+0.1% | $331.36M+0.3% | $330.38M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AnaptysBio, Inc.'s total assets?
- AnaptysBio, Inc. (ANAB) holds $329.7M in total assets, down 21.9% year over year.
- How much debt does AnaptysBio, Inc. have?
- AnaptysBio, Inc. carries $13.6K in total debt against $12.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does AnaptysBio, Inc. have?
- AnaptysBio, Inc. holds $248.5M in cash and equivalents.
- Can AnaptysBio, Inc. cover its short-term obligations?
- Its current ratio is 7.58 — current assets exceed current liabilities.
- Where does AnaptysBio, Inc.'s balance sheet data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
